exam 3 lecture 9 mucosal Flashcards

1
Q

mucosal drug delivery

A

via accessible body cavities covered with mucosa –> more permeable
oral (buccal, sublingual, gingival)
nasal
vaginal
intrauterine
rectal
ocular
pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

advantages of mucosal drug delivery

A

avoid first pass
noninvasive
relative ease and convenience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

disadvantages mucosal drug delivery

A

small area of absorption
taste
delivery limited MW of drug
local irriation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mucus

A

secreted by globlet cells/ salivary glands
functions: coats entry points, protects underlying tissue, keeps membranes moist
thickness varies: <1 um in oral cavity, 450 um in stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mucus components

A

mostly water
mucins (glycoproteins)
lipids
inorganic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mucin

A

glycoproteins: 20% proteins + 80% glycosylated carbs
extra large molecules membrane bound or secreted
gel-like structure of mucus
negative charge due to high sialic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mucin structure

A

sialic acid (-): carboxylic + hydroxyl groups
galactose
n-acetyleglucosamine
core sugars
protein
- contains cysteine rich domains for disulfide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mucoadhesion

A

hydrogen bonding
state where polymers and mucus are held together by interfacial bonds
prolongs residence time of dosage form on the mucosal surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

puprposes of mucoadhesion

A

controlled released system
enhancement of poorly absorbed drug molecules
immobilization of dosage form at site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mechanisms of mucoadhesion

A

electrostatic interaction: positive charge of polymer and negative charge of sialic acid
H-bond
covalent bonding: disulfide bonds between thiolated polymer and cysteine-rich portion of mucin
physical interpenetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

oral mucosal

A

systemic or local
sublingual: more permeable and faster
buccal: less permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

advantages of oral mucosa

A

avoid first pass
rapid absorption/onset of drug
easy to remove if therapy needs to be discontinued

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

disadvantage oral mucosa

A

small surface area
limited by taste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sublingual

A

relatively permeable
rapid onset
suitable for frequent dosing
nitroglycerin sublingual tab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

buccal

A

relatively less permeable
slower absorption and onset of action
less influenced by saliva
suitable for sustained delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drug absorption oral mucosa

A

mechanisms:
-transcellular (intracellular)
-paracellular (intercellular)
absorbed into reticulated and jugular veins
drained into systemic circulation (first pass

17
Q

oral drug characteristics

A

predominantly lipophillic
mostly small MW drugs
maybe hydrophillic macromolecular weight

18
Q

buccal tablets

A

bioadhesive polymer layer (polyacrylic acids, cellulose)
matrix containing API and excipients
ex: oravig (miconazole) + fentora ( cephalon)
applying oravig: flat side on fingertip and push into upper gum

19
Q

atiq

A

cephalon
good bioavailability
lozenge on a stick
dosage form is rotating and dissolving against mucosal tissue
self-administer drugs to oral cavity is either transmucosal or GI absorption

20
Q

buccal patch

A

thinner and more flexible than buccal tabs
less obtrusive and more acceptable to patients

21
Q

advantage of nasal

A

avoids first pass elimination and destruction in GI
rapid absorption of drug molecules
relatively easy and convientn

22
Q

disadvantage nasal

A

possible tissue irritation
rapid removal of drug at site absorption
pathological conditions like cold/allergies may alter nasal bioavail
limited area of drug absorption

23
Q

nasal examples

A

zicam - zinc for cold symptoms
miacalcin - calcitonin for post-menopausal osteoporosis

24
Q

nasal cavity

A

respiratory region: main site for systemic drug delivery
- epithelium covered with mucus for humidification and warming of inhaled air
olfactory region: provides connection from CNS to atmosphere, contains small glands that produce secretions acting as a solvent for odorous

25
nasal vaccines
nasal mucosa: first site of contact with inhaled antigens (influenza) lymphoid tissue underneath nasal epithelium vaccination against respiratory infections
26
advantage of vaginal mucosa
rich blood supply high permeability to certain drugs avoidance of first pass
27
disadvantage vaginal mucosa
hormone-dependent changes (pH)
28
vaginal delivery systems
gels + creams: most widely used, drawback is leakage/mess/applicator films vaginal rings: pliable drug delivery device inserted into vagina
29
IUD
small plastic device placed into uterine cavity for sustained UID drug release of contraception local progestogenic effects in UID cavity zero order release up to 5 years
30
rectal mucosa
oral drugs can be admin by lower enteral route through anal portion / rectum local: IBD systemic: when oral admin not feasible suppositories: solid dosage form for rectal insertion rectal emenas: liquids introduced into rectum and colon via anus PED and geriatrics
31
ocular
local: great need for ocular drug delivery requirements for ocular drug delivery: -need to be clear - good corneal penetration - prolonged contact time with corneal epithelium - simplicity of use - non- irritating, comfortable
32
challenges in ocular delivery
loss due to dilution bc of tear film short residence time not much flexibility in formulation adjustments
33
ocular dosage forms
eye drops - reduce drainage ointments ocusert contact lenses erodable/ non-erodable implants
34
intraocular implants
ciliart neurotrophic factor: proteons neural cells including photoreceptors --> slows retinal degradation blood-retina barrier: restricts drug access from blood to retina tissue oscular implant: loaded with human retinal pigment epithelium cells with CNTF gene to produce CNTF in situ
35
encapsulated cell technology
semi-permeable membrane allows oxygen and nutrients to cross and come in allows drug to come out does not allow immune cells to come in